Skip to main content

Advertisement

Log in

The effect of drugs on serum histidine levels in rheumatoid arthritis

  • Originals
  • Published:
Rheumatology International Aims and scope Submit manuscript

Summary

Groups of 15 patients with active rheumatoid arthritis were treated for 24 weeks with zinc sulphate, trien, captopril, clozic in two doses or a combination of d-penicillamine and hydroxychloroquine. Serum histidine levels were monitored along with measures of disease activity including C-reactive protein, plasma viscosity, articular index, grip strength and early morning stiffness. Zinc sulphate and trien were found to be ineffective while the other drugs all showed evidence of second-line action. Serum histidine was found to improve during successful therapy. The possible cause of low serum histidine and its response to therapy is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Gerber DA (1975) Decreased concentration of free histidine in serum in rheumatoid arthritis, an isolated amino acid abnormality not associated with generalised hypoaminoacidemia. J Rheumatol 2:384–392

    Google Scholar 

  2. Pickup ME, Dixon JS, Lowe JR, Wright V (1980) Serum histidine in rheumatoid arthritis: Changes induced by anti-rheumatic drug therapy. J Rheumatol 7:71–76

    Google Scholar 

  3. Gerber DA (1977) Anti-rheumatic drugs, the ESR, and the hypohistidinemia of rheumatoid arthritis. J Rheumatol 4:40–45

    Google Scholar 

  4. Dixon JS (1982) Biochemical and clinical changes in rheumatoid arthritis: their relation to the action of antirheumatoid drugs. Semin Arthritis Rheum 12:191–207

    Google Scholar 

  5. Simkin PA (1981) Treatment of rheumatoid arthritis with oral zinc sulphate. Agents Actions (Suppl) 8:587–596

    Google Scholar 

  6. Martin MFR, Surrall K, McKenna F, Dixon JS, Bird HA, Wright V (1983) Captopril. A new long term agent for treating rheumatoid arthritis. Heberden Society, London. Ann Rheum Dis 42:231

    Google Scholar 

  7. Sarkar B, Sass-Kortsack A, Clarke R, Laurie SH, Wei P (1977) A comparative study of in vitro and in vivo interaction of d-penicillamine and triethylenetetramine with copper. Proc R Soc Med 70:13–18

    Google Scholar 

  8. Martin M, Sitton N, Dixon J, Hickling P, Golding J, Wright V (1982) Penicillamine failures — what can be done? Heberden Society, Cambridge. Ann Rheum Dis 41:631–632

    Google Scholar 

  9. Gerber DA (1970) Determination of histidine in serum with o-phthaldialdehyde. Anal Biochem 34:500–504

    Google Scholar 

  10. Pickup ME, Dixon JS, Hallett C, Bird HA, Wright V (1981) Plasma viscosity — a new appraisal of its use as an index of disease activity in rheumatoid arthritis. Ann Rheum Dis 40:272–275

    Google Scholar 

  11. Dixon JS, Bird HA, Sitton NG, Pickup ME, Wright V (in press) C-reactive protein in the serial assessment of disease activity in rheumatoid arthritis. Scand J Rheumatol

  12. Pickup ME, Dixon JS, Bird HA (1980) On the effects of antirheumatic drugs on protein sulphydryl reactivity in human serum. J Pharm Pharmacol 32:301–302

    Google Scholar 

  13. Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW (1968) Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. J Med 37:393–406

    Google Scholar 

  14. Gerber DA (1981) Possible role of copper complex in the pathogenesis of rheumatoid arthritis. Agents Actions (Suppl) 8:165–184

    Google Scholar 

  15. Gerber DA (1975) Low free serum histidine concentration in rheumatoid arthritis. A measure of disease activity. J Clin Invest 55:1164–1173

    Google Scholar 

  16. Dixon JS, Bird HA, Wright V (1981) A comparison of serum biochemistry in ankylosing spondylitis, seronegative and seropositive rheumatoid arthritis. Ann Rheum Dis 40:404–408

    Google Scholar 

  17. Gerber DA, Gerber MG (1977) Specificity of a low free serum histidine concentration for rheumatoid arthritis. J Chronic Dis 30:115–127

    Google Scholar 

  18. Kirkham J, Lowe J, Bird HA, Wright V (1981) Serum histidine in rheumatoid arthritis: a family study. Ann Rheum Dis 40:501–502

    Google Scholar 

  19. Simkin PA (1976) Oral zinc sulphate in rheumatoid arthritis. Lancet II:539–542

    Google Scholar 

  20. Hallman PS, Perrin DD, Watt AE (1971) The computed distribution of copper (II) and zinc (II) Ions among 17 amino acids present in human blood plasma. Biochem J 121:549–555

    Google Scholar 

  21. Brown DH, Buchanan WW, El-Ghobarey AF, Smith WE, Teape J (1979) Serum copper and its relationship to clinical symptoms in rheumatoid arthritis. Ann Rheum Dis 38:174–176

    Google Scholar 

  22. Bajpayee DP (1975) Significance of plasma copper and caeruloplasmin concentrations in rheumatoid arthritis. Ann Rheum Dis 34:162–165

    Google Scholar 

  23. Koj A (1974) Acute-phase reactants. In: Allison AC (ed) Structure and function of plasma proteins, vol 1. Plenum Press, New York London, pp 73–132

    Google Scholar 

  24. Powanda MC, Cockerell GL, Pekarek RS (1973) Amino acid and zinc movement in relation to protein synthesis early in inflammation. Am J Physiol 225:399–401

    Google Scholar 

  25. Badway JA, Karnovsky ML (1980) Active oxygen species and the functions of phagocytic leukocytes. Annu Rev Biochem 49:695–726

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dixon, J.S., Sitton, N.G., Surrall, K.E. et al. The effect of drugs on serum histidine levels in rheumatoid arthritis. Rheumatol Int 3, 145–149 (1983). https://doi.org/10.1007/BF00541592

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00541592

Key words

Navigation